Initially perhaps, but do we have good longer term data on how the sinovac holds up, given we're now saying Pfizer needs to be 3-monthly and Moderna is a much stronger dose? I think there was some over-selling of the mRNA vaccines that needs strong follow-up review given the state of the virus vs last year without vaccines with a more potent variant.